Commission rejects health claim on beta-glucans in ready-to-eat breakfast cereal

Application – Relevant provisions of Regulation (EC) No 1924/2006

Nutrient, substance, food or food category

Claim

EFSA opinion reference

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Beta-glucans sourced from oats and/or barley, incorporated into ready-to-eat breakfast cereals manufactured via pressure cooking (i.e. either by batch cooking or extrusion), and present at a level of at least 1,3 g per 25 g available carbohydrate in the ready-to-eat cereal

Consumption of beta-glucans from oats and/or barley in a ready-to-eat breakfast cereal contributes to a reduction of the blood glucose rise after that meal

Q-2020-000447

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Affron®, aqueous saffron extract, with the sum of crocins and safranal concentration > 3,5 % and dextrin as inert carrier

Affron® contributes to maintain a healthy mood by reducing the negative traits of depressive and anxiety feelings

Q-2020-00617

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

MegaNatural®-BP grape seed extract made entirely of California-grown grapes containing biologically active constituents: total phenolics (90–93 %), gallic acid (≥ 2 %) and catechin and epicatechin (≥ 5 %). The distribution of phenolic compounds in the MegaNatural®-BP is on average 9 % monomers, 69 % oligomers and 22 % polymers

MegaNatural®-BP helps maintain healthy blood pressure

Q-2020-00718

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Frutalose® chicory oligofructose

Frutalose® chicory oligofructose contributes to regular bowel function by increasing stool frequency

(And three other alternative wordings)

Q-2020-00631